UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000035330 |
|---|---|
| Receipt number | R000040251 |
| Scientific Title | Objective evaluation of cancer pain using non-contact sensor |
| Date of disclosure of the study information | 2018/12/20 |
| Last modified on | 2023/06/28 13:51:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Objective evaluation of cancer pain using non-contact sensor
Acronym
Objective evaluation of cancer pain using non-contact sensor
Scientific Title
Objective evaluation of cancer pain using non-contact sensor
Scientific Title:Acronym
Objective evaluation of cancer pain using non-contact sensor
Region
| Japan |
Condition
Condition
Cancer
Healthy individuals
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to examine the possibility of objective rating of cancer pain using a non-contact sensing system.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Quantification of cancer pain
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Device,equipment |
Interventions/Control_1
Patients with cancer pain and healthy individuals
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Cancer patients
Patients who have confirmed cancer diagnosis and are notified
Patients with persistent or intermittent pain thought to be due to cancer
Healthy individuals
Individuals without pain
Individuals without chronic diseases
Key exclusion criteria
Cancer patients
Patients with other strong symptoms other than cancer pain
Patients who are expected to develop rapid medical condition
Patients with visual acuity / hearing impairment
Patients with skin disease on the face
Healthy individuals
Individuals with visual acuity / hearing impairment
Individuals with skin disease on the face
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Akira |
| Middle name | |
| Last name | Yamasaki |
Organization
Tottori University Faculty of Medicine
Division name
Division of Medical Oncology and Molecular Respirology
Zip code
683-8504
Address
36-1 Nishi-cho, Yonago, Tottori
TEL
0859-38-6537
yamasaki@tottori-u.ac.jp
Public contact
Name of contact person
| 1st name | Kosuke |
| Middle name | |
| Last name | Yamaguchi |
Organization
Tottori University Faculty of Medicine
Division name
Division of Medical Oncology and Molecular Respirology
Zip code
683-8504
Address
36-1 Nishi-cho, Yonago, Tottori
TEL
0859-38-6537
Homepage URL
kske2@tottori-u.ac.jp
Sponsor or person
Institute
Tottori University Faculty of Medicine
Institute
Department
Personal name
Funding Source
Organization
Tottori University Faculty of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tottori University Faculty of Medicine
Address
36-1 Nishi-cho, Yonago, Tottori
Tel
0859-38-7014
me-rinshoukenkyu@ml.adm.tottori-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 12 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2016 | Year | 11 | Month | 01 | Day |
Date of IRB
| 2016 | Year | 10 | Month | 13 | Day |
Anticipated trial start date
| 2016 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2018 | Year | 12 | Month | 20 | Day |
Last modified on
| 2023 | Year | 06 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040251
